{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:05:33Z","timestamp":1795089933265,"version":"4.10.2"},"reference-count":141,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4,20]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Chimeric antigen receptor T (CAR-T) cell therapy achieved advanced progress in the treatment of hematological tumors. However, the application of CAR-T cell therapy for solid tumors still faces many challenges. Competition with tumor cells for metabolic resources in an already nutrient-poor tumor microenvironment is a major contributing cause to CAR-T cell therapy\u2019s low effectiveness. Abnormal metabolic processes are now acknowledged to shape the tumor microenvironment, which is characterized by increased interstitial fluid pressure, low pH level, hypoxia, accumulation of immunosuppressive metabolites, and mitochondrial dysfunction. These factors are important contributors to restriction of T cell proliferation, cytokine release, and suppression of tumor cell-killing ability. This review provides an overview of how different metabolites regulate T cell activity, analyzes the current dilemmas, and proposes key strategies to reestablish the CAR-T cell therapy\u2019s effectiveness through targeting metabolism, with the aim of providing new strategies to surmount the obstacle in the way of solid tumor CAR-T cell treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000003046","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T10:07:53Z","timestamp":1710842873000},"page":"909-920","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":25,"title":["Targeting metabolism to improve CAR-T cells therapeutic efficacy"],"prefix":"10.1097","volume":"137","author":[{"given":"Shasha","family":"Liu","sequence":"first","affiliation":[{"name":"Biotherapy Center and Cancer Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyu","family":"Zhao","sequence":"additional","affiliation":[{"name":"Biotherapy Center and Cancer Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China"},{"name":"School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoxin","family":"Gao","sequence":"additional","affiliation":[{"name":"Biotherapy Center and Cancer Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[{"name":"Biotherapy Center and Cancer Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China"},{"name":"Engineering Key Laboratory for Cell Therapy of Henan Province, Zhengzhou, Henan 450052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Biotherapy Center and Cancer Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China"},{"name":"School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450052, China"},{"name":"Engineering Key Laboratory for Cell Therapy of Henan Province, Zhengzhou, Henan 450052, China"},{"name":"School of Public Health, Zhengzhou University, Zhengzhou, Henan 450000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,3,19]]},"reference":[{"key":"R1-20250602","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41586-023-06243-w","article-title":"CAR T therapy beyond cancer: the evolution of a living drug","volume":"619","author":"Baker","year":"2023","journal-title":"Nature"},{"key":"R2-20250602","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41586-023-05707-3","article-title":"CAR immune cells: design principles, resistance and the next generation","volume":"614","author":"Labanieh","year":"2023","journal-title":"Nature"},{"key":"R3-20250602","doi-asserted-by":"crossref","first-page":"239","DOI":"10.21147\/j.issn.1000-9604.2023.03.03","article-title":"Challenges and interventions of chimeric antigen receptor-T cell therapy in solid tumors","volume":"35","author":"Liu","year":"2023","journal-title":"Chin J Cancer Res"},{"key":"R5-20250602","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13045-020-00890-6","article-title":"Gene modification strategies for next-generation CAR T cells against solid cancers","volume":"13","author":"Tian","year":"2020","journal-title":"J Hematol Oncol"},{"key":"R6-20250602","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41571-023-00754-1","article-title":"Long-term outcomes following CAR T cell therapy: what we know so far","volume":"20","author":"Cappell","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"R7-20250602","first-page":"2285","article-title":"Clinical development of chimeric antigen receptor-T cell therapy for hematological malignancies","volume":"136","author":"Yang","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"R8-20250602","first-page":"269","article-title":"Challenges and optimal strategies of CAR T therapy for hematological malignancies","volume":"136","author":"Zhang","year":"2023","journal-title":"Chin Med J"},{"key":"R9-20250602","article-title":"Chimeric antigen receptor-immune cells against solid tumors: Structures, mechanisms, recent advances, and future developments","author":"Li","year":"2023","journal-title":"Chin Med J"},{"key":"R10-20250602","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/imr.12858","article-title":"Immunometabolism: From basic mechanisms to translation","volume":"295","author":"Makowski","year":"2020","journal-title":"Immunol Rev"},{"key":"R11-20250602","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.cell.2023.01.038","article-title":"What is cancer metabolism","volume":"186","author":"Finley","year":"2023","journal-title":"Cell"},{"key":"R12-20250602","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s42255-020-00280-9","article-title":"Metabolic and epigenetic regulation of T-cell exhaustion","volume":"2","author":"Franco","year":"2020","journal-title":"Nat Metab"},{"key":"R13-20250602","doi-asserted-by":"crossref","first-page":"eabq3016","DOI":"10.1126\/sciimmunol.abq3016","article-title":"Metabolic challenges and interventions in CAR T cell therapy","volume":"8","author":"Peng","year":"2023","journal-title":"Sci Immunol"},{"key":"R14-20250602","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41571-019-0203-7","article-title":"Navigating metabolic pathways to enhance antitumour immunity and immunotherapy","volume":"16","author":"Li","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"R15-20250602","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.cmet.2022.03.013","article-title":"The mitochondrial pyruvate carrier regulates memory T\u00a0cell differentiation and antitumor function","volume":"34","author":"Wenes","year":"2022","journal-title":"Cell Metab"},{"key":"R16-20250602","doi-asserted-by":"crossref","first-page":"1242454","DOI":"10.1126\/science.1242454","article-title":"Fueling immunity: insights into metabolism and lymphocyte function","volume":"342","author":"Pearce","year":"2013","journal-title":"Science"},{"key":"R17-20250602","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.cell.2015.08.012","article-title":"Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses","volume":"162","author":"Ho","year":"2015","journal-title":"Cell"},{"key":"R18-20250602","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fcell.2020.00017","article-title":"T Cell Dysfunction and Exhaustion in Cancer","volume":"8","author":"Zhang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"R19-20250602","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"R20-20250602","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41577-019-0203-y","article-title":"Metabolic coordination of T cell quiescence and activation","volume":"20","author":"Chapman","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"R21-20250602","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2015.00001","article-title":"Glucose metabolism regulates T cell activation, differentiation, and functions","volume":"6","author":"Palmer","year":"2015","journal-title":"Front Immunol"},{"key":"R22-20250602","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cmet.2014.05.004","article-title":"The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function","volume":"20","author":"Macintyre","year":"2014","journal-title":"Cell Metab"},{"key":"R23-20250602","doi-asserted-by":"crossref","first-page":"103627","DOI":"10.1016\/j.ebiom.2021.103627","article-title":"Lactate in the tumour microenvironment: From immune modulation to therapy","volume":"73","author":"Wang","year":"2021","journal-title":"EBioMedicine"},{"key":"R24-20250602","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s11427-020-1887-7","article-title":"Lactate anions participate in T cell cytokine production and function","volume":"64","author":"Wen","year":"2021","journal-title":"Sci China Life Sci"},{"key":"R25-20250602","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1038\/s41467-022-32521-8","article-title":"Lactate increases stemness of CD8\u2009+\u2009T cells to augment anti-tumor immunity","volume":"13","author":"Feng","year":"2022","journal-title":"Nat Commun"},{"key":"R26-20250602","doi-asserted-by":"crossref","first-page":"eadd9554","DOI":"10.1126\/sciadv.add9554","article-title":"The lactate dehydrogenase (LDH) isoenzyme spectrum enables optimally controlling T cell glycolysis and differentiation","volume":"9","author":"Chen","year":"2023","journal-title":"Sci Adv"},{"key":"R27-20250602","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.abb2683","article-title":"Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity","volume":"371","author":"Xu","year":"2021","journal-title":"Science"},{"key":"R28-20250602","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.cmet.2020.07.008","article-title":"Sirt2 Inhibition Enhances Metabolic Fitness and Effector Functions of Tumor-Reactive T Cells","volume":"32","author":"Hamaidi","year":"2020","journal-title":"Cell Metab"},{"key":"R29-20250602","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","article-title":"Lactic acid promotes PD-1 expression in regulatory T\u00a0cells in highly glycolytic tumor microenvironments","volume":"40","author":"Kumagai","year":"2022","journal-title":"Cancer Cell"},{"key":"R30-20250602","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.cmet.2023.07.001","article-title":"Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T\u00a0cell-mediated bystander killing via TNF-\u03b1","volume":"35","author":"Wu","year":"2023","journal-title":"Cell Metab"},{"key":"R31-20250602","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1016\/j.molcel.2022.06.002","article-title":"TCR activation directly stimulates PYGB-dependent glycogenolysis to fuel the early recall response in CD8+ memory T\u00a0cells","volume":"82","author":"Zhang","year":"2022","journal-title":"Mol Cell"},{"key":"R32-20250602","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41589-022-01017-3","article-title":"Lipid metabolism in T cell signaling and function","volume":"18","author":"Lim","year":"2022","journal-title":"Nat Chem Biol"},{"key":"R33-20250602","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz6314","article-title":"Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy","volume":"13","author":"Liu","year":"2021","journal-title":"Sci Transl Med"},{"key":"R34-20250602","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.it.2014.12.005","article-title":"Fatty acid metabolism in the regulation of T cell function","volume":"36","author":"Lochner","year":"2015","journal-title":"Trends Immunol"},{"key":"R35-20250602","doi-asserted-by":"crossref","first-page":"14336","DOI":"10.1073\/pnas.1221740110","article-title":"CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability","volume":"110","author":"van der Windt","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R36-20250602","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/intimm\/dxac025","article-title":"Fatty acid metabolism in T-cell function and differentiation","volume":"34","author":"Endo","year":"2022","journal-title":"Int Immunol"},{"key":"R37-20250602","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3389\/fimmu.2017.01949","article-title":"The Role of Lipid Metabolism in T Lymphocyte Differentiation and Survival","volume":"8","author":"Howie","year":"2017","journal-title":"Front Immunol"},{"key":"R38-20250602","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","article-title":"Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T\u00a0cells in tumors","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity"},{"key":"R39-20250602","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211314","article-title":"CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate","volume":"219","author":"Chen","year":"2022","journal-title":"J Exp Med"},{"key":"R40-20250602","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","article-title":"CD36-mediated ferroptosis dampens intratumoral CD8+ T\u00a0cell effector function and impairs their antitumor ability","volume":"33","author":"Ma","year":"2021","journal-title":"Cell Metab"},{"key":"R41-20250602","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cmet.2023.02.013","article-title":"Linoleic acid potentiates CD8+ T\u00a0cell metabolic fitness and antitumor immunity","volume":"35","author":"Nava Lauson","year":"2023","journal-title":"Cell Metab"},{"key":"R42-20250602","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.immuni.2018.07.018","article-title":"Memory CD8+ T Cells Use Cell-Intrinsic Lipolysis to Support the Metabolic Programming Necessary for Development","volume":"49","author":"O\u2019Sullivan","year":"2018","journal-title":"Immunity"},{"key":"R43-20250602","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/imr.12655","article-title":"Fatty acid metabolism in CD8+ T cell memory: Challenging current concepts","volume":"283","author":"Raud","year":"2018","journal-title":"Immunol Rev"},{"key":"R44-20250602","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ccell.2017.08.004","article-title":"Enhancing CD8+ T Cell Fatty Acid Catabolism within\u00a0a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy","volume":"32","author":"Zhang","year":"2017","journal-title":"Cancer Cell"},{"key":"R45-20250602","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","article-title":"Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment","volume":"30","author":"Ma","year":"2019","journal-title":"Cell Metab"},{"key":"R46-20250602","doi-asserted-by":"crossref","first-page":"1118448","DOI":"10.3389\/fimmu.2023.1118448","article-title":"Influenced tumor microenvironment and tumor immunity by amino acids","volume":"14","author":"Yu","year":"2023","journal-title":"Front Immunol"},{"key":"R47-20250602","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"key":"R48-20250602","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cmet.2022.02.009","article-title":"A genome-scale gain-of-function CRISPR screen in CD8 T\u00a0cells identifies proline metabolism as a means to enhance CAR-T therapy","volume":"34","author":"Ye","year":"2022","journal-title":"Cell Metab"},{"key":"R49-20250602","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cmet.2016.12.011","article-title":"Serine Is an Essential Metabolite for Effector T Cell Expansion","volume":"25","author":"Ma","year":"2017","journal-title":"Cell Metab"},{"key":"R50-20250602","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4049\/jimmunol.0903586","article-title":"Glutamine uptake and metabolism are coordinately regulated by ERK\/MAPK during T lymphocyte activation","volume":"185","author":"Carr","year":"2010","journal-title":"J Immunol"},{"key":"R51-20250602","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41556-020-00615-4","article-title":"Asparagine enhances LCK signalling to potentiate CD8+ T-cell activation and anti-tumour responses","volume":"23","author":"Wu","year":"2021","journal-title":"Nat Cell Biol"},{"key":"R52-20250602","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cmet.2020.01.006","article-title":"Methionine Metabolism Shapes T Helper Cell Responses through Regulation of Epigenetic Reprogramming","volume":"31","author":"Roy","year":"2020","journal-title":"Cell Metab"},{"key":"R53-20250602","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41590-022-01365-1","article-title":"Ammonia detoxification promotes CD8+ T cell memory development by urea and citrulline cycles","volume":"24","author":"Tang","year":"2023","journal-title":"Nat Immunol"},{"key":"R54-20250602","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1042\/BST20190033","article-title":"Nicotinamide adenine dinucleotide (NAD+): essential redox metabolite, co-substrate and an anti-cancer and anti-ageing therapeutic target","volume":"48","author":"Griffiths","year":"2020","journal-title":"Biochem Soc Trans"},{"key":"R55-20250602","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3389\/fimmu.2019.00925","article-title":"Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function","volume":"10","author":"Vigano","year":"2019","journal-title":"Front Immunol"},{"key":"R56-20250602","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2016.07.032","article-title":"Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche","volume":"166","author":"Clever","year":"2016","journal-title":"Cell"},{"key":"R57-20250602","doi-asserted-by":"crossref","first-page":"224ra25","DOI":"10.1126\/scitranslmed.3008226","article-title":"Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia","volume":"6","author":"Davila","year":"2014","journal-title":"Sci Transl Med"},{"key":"R58-20250602","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"R59-20250602","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"R60-20250602","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/s41418-023-01125-0","article-title":"Cuproptosis: p53-regulated metabolic cell death","volume":"30","author":"Xiong","year":"2023","journal-title":"Cell Death Differ"},{"key":"R61-20250602","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nature19364","article-title":"Ionic immune suppression within the tumour microenvironment limits T cell effector function","volume":"537","author":"Eil","year":"2016","journal-title":"Nature"},{"key":"R62-20250602","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau0135","article-title":"T cell stemness and dysfunction in tumors are triggered by a common mechanism","volume":"363","author":"Vodnala","year":"2019","journal-title":"Science"},{"key":"R63-20250602","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4049\/jimmunol.168.2.689","article-title":"Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism","volume":"168","author":"Mazzoni","year":"2002","journal-title":"J Immunol"},{"key":"R64-20250602","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1158\/2326-6066.CIR-16-0382","article-title":"Role of NOX2-Derived Reactive Oxygen Species in NK Cell-Mediated Control of Murine Melanoma Metastasis","volume":"5","author":"Aydin","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"R65-20250602","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41571-023-00832-4","article-title":"CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn","volume":"21","author":"Albelda","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"R66-20250602","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nbt.4180","article-title":"Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme","volume":"36","author":"Triplett","year":"2018","journal-title":"Nat Biotechnol"},{"key":"R67-20250602","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1182\/blood-2015-01-621474","article-title":"Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs","volume":"125","author":"Ninomiya","year":"2015","journal-title":"Blood"},{"key":"R68-20250602","doi-asserted-by":"crossref","first-page":"200ra116","DOI":"10.1126\/scitranslmed.3006504","article-title":"Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells","volume":"5","author":"Spranger","year":"2013","journal-title":"Sci Transl Med"},{"key":"R69-20250602","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.1158\/1078-0432.CCR-17-0120","article-title":"Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival","volume":"23","author":"Zhai","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R70-20250602","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1158\/2326-6066.CIR-16-0182","article-title":"Promoter Methylation Modulates Indoleamine 2,3-Dioxygenase 1 Induction by Activated T Cells in Human Breast Cancers","volume":"5","author":"Noonepalle","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"R71-20250602","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/leu.2015.247","article-title":"Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo","volume":"30","author":"Sommermeyer","year":"2016","journal-title":"Leukemia"},{"key":"R72-20250602","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1158\/0008-5472.CAN-14-2277","article-title":"Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics","volume":"75","author":"Crompton","year":"2015","journal-title":"Cancer Res"},{"key":"R73-20250602","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08155","article-title":"mTOR regulates memory CD8 T-cell differentiation","volume":"460","author":"Araki","year":"2009","journal-title":"Nature"},{"key":"R74-20250602","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1158\/0008-5472.CAN-16-1925","article-title":"Enhanced Therapeutic Efficacy and Memory of Tumor-Specific CD8 T Cells by Ex Vivo PI3K-\u03b4 Inhibition","volume":"77","author":"Abu Eid","year":"2017","journal-title":"Cancer Res"},{"key":"R75-20250602","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13045-018-0600-x","article-title":"miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy","volume":"11","author":"Huang","year":"2018","journal-title":"J Hematol Oncol"},{"key":"R76-20250602","doi-asserted-by":"crossref","first-page":"661357","DOI":"10.3389\/fimmu.2021.661357","article-title":"Indoleamine 2,3-Dioxygenase 1 Inhibitor-Loaded Nanosheets Enhance CAR-T Cell Function in Esophageal Squamous Cell Carcinoma","volume":"12","author":"Shao","year":"2021","journal-title":"Front Immunol"},{"issue":"11","key":"R77-20250602","doi-asserted-by":"crossref","first-page":"2055703","DOI":"10.1080\/2162402X.2022.2055703","article-title":"Superior antitumor immunotherapy efficacy of kynureninase modified CAR-T cells through targeting kynurenine metabolism","volume":"25","author":"Yang","year":"2022","journal-title":"Oncoimmunology"},{"key":"R78-20250602","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1158\/2326-6066.CIR-15-0263","article-title":"Augmentation of CAR T-cell Trafficking and Antitumor Efficacy by Blocking Protein Kinase A Localization","volume":"4","author":"Newick","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"R79-20250602","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12943-017-0665-0","article-title":"Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma","volume":"16","author":"Ma","year":"2017","journal-title":"Mol Cancer"},{"key":"R80-20250602","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ccell.2016.06.025","article-title":"Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses","volume":"30","author":"Young","year":"2016","journal-title":"Cancer Cell"},{"key":"R81-20250602","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00262-018-2186-0","article-title":"Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models","volume":"67","author":"Leone","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"R82-20250602","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1038\/s41467-021-23331-5","article-title":"CRISPR\/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy","volume":"12","author":"Giuffrida","year":"2021","journal-title":"Nat Commun"},{"key":"R83-20250602","doi-asserted-by":"crossref","first-page":"112886","DOI":"10.1016\/j.yexcr.2021.112886","article-title":"Disruption of adenosine 2A receptor improves the anti-tumor function of anti-mesothelin CAR T cells both in vitro and in vivo","volume":"409","author":"Liu","year":"2021","journal-title":"Exp Cell Res"},{"key":"R84-20250602","doi-asserted-by":"crossref","first-page":"1824643","DOI":"10.1080\/2162402X.2020.1824643","article-title":"Improving the anti-solid tumor efficacy of CAR-T cells by inhibiting adenosine signaling pathway","volume":"9","author":"Li","year":"2020","journal-title":"Oncoimmunology"},{"key":"R85-20250602","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13046-020-01546-6","article-title":"Genetic and pharmacological targeting of A2a receptor improves function of anti-mesothelin CAR T cells","volume":"39","author":"Masoumi","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"R86-20250602","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.imlet.2020.04.005","article-title":"Pharmacological targeting of immune checkpoint A2aR improves function of anti-CD19 CAR T cells in vitro","volume":"223","author":"Fallah-Mehrjardi","year":"2020","journal-title":"Immunol Lett"},{"key":"R87-20250602","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1172\/JCI89455","article-title":"Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy","volume":"127","author":"Beavis","year":"2017","journal-title":"J Clin Invest"},{"key":"R88-20250602","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1158\/2326-6066.CIR-17-0502","article-title":"CAR-T Cells Surface-Engineered with Drug-Encapsulated Nanoparticles Can Ameliorate Intratumoral T-cell Hypofunction","volume":"6","author":"Siriwon","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"R89-20250602","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0952-7915(91)90019-W","article-title":"Severe combined immunodeficiency disease, adenosine deaminase deficiency and gene therapy","volume":"3","author":"Parkman","year":"1991","journal-title":"Curr Opin Immunol"},{"key":"R90-20250602","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/hum.2021.050","article-title":"Adenosine Deaminase 1 Overexpression Enhances the Antitumor Efficacy of Chimeric Antigen Receptor-Engineered T Cells","volume":"33","author":"Qu","year":"2022","journal-title":"Hum Gene Ther"},{"key":"R91-20250602","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/s41591-018-0095-6","article-title":"Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate","volume":"24","author":"Bunse","year":"2018","journal-title":"Nat Med"},{"key":"R92-20250602","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1158\/1078-0432.CCR-17-3855","article-title":"D-2-Hydroxyglutarate Is an Intercellular Mediator in IDH-Mutant Gliomas Inhibiting Complement and T Cells","volume":"24","author":"Zhang","year":"2018","journal-title":"Clin Cancer Res"},{"key":"R93-20250602","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.ymthe.2022.01.007","article-title":"D2HGDH-mediated D2HG catabolism enhances the anti-tumor activities of CAR-T cells in an immunosuppressive microenvironment","volume":"30","author":"Yang","year":"2022","journal-title":"Mol Ther"},{"key":"R94-20250602","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1182\/blood.2019004500","article-title":"Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activity","volume":"136","author":"Fultang","year":"2020","journal-title":"Blood"},{"key":"R95-20250602","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The Emerging Hallmarks of Cancer Metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab"},{"key":"R96-20250602","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"R97-20250602","doi-asserted-by":"crossref","DOI":"10.3390\/cells11193103","article-title":"Reprogramming T-Cell Metabolism for Better Anti-Tumor Immunity","volume":"11","author":"Ping","year":"2022","journal-title":"Cells"},{"key":"R98-20250602","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/mco2.6","article-title":"Metabolism in tumor microenvironment: Implications for cancer immunotherapy","volume":"1","author":"Shi","year":"2020","journal-title":"MedComm (2020)"},{"key":"R99-20250602","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13045-021-01200-4","article-title":"Contradictory roles of lipid metabolism in immune response within the tumor microenvironment","volume":"14","author":"Yu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"R100-20250602","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41423-021-00833-2","article-title":"Microenvironmental influences on T cell immunity in cancer and inflammation","volume":"19","author":"Heintzman","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"R101-20250602","doi-asserted-by":"crossref","first-page":"976628","DOI":"10.3389\/fimmu.2022.976628","article-title":"Enforcing GLUT3 expression in CD8+ T cells improves fitness and tumor control by promoting glucose uptake and energy storage","volume":"13","author":"Cribioli","year":"2022","journal-title":"Front Immunol"},{"key":"R102-20250602","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.138729","article-title":"CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation","volume":"5","author":"Beckermann","year":"2020","journal-title":"JCI Insight"},{"key":"R103-20250602","doi-asserted-by":"crossref","first-page":"E242","DOI":"10.1152\/ajpendo.90388.2008","article-title":"The facilitative glucose transporter GLUT3: 20 years of distinction","volume":"295","author":"Simpson","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R104-20250602","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41591-018-0010-1","article-title":"Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia","volume":"24","author":"Fraietta","year":"2018","journal-title":"Nat Med"},{"key":"R105-20250602","article-title":"Improved CAR-T cell activity associated with increased mitochondrial function primed by galactose","author":"Gross","year":"2023","journal-title":"bioRxiv"},{"key":"R106-20250602","article-title":"Inosine Induces Stemness Features in CAR T cells and Enhances Potency","author":"Klysz","year":"2023","journal-title":"bioRxiv"},{"key":"R107-20250602","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2016.05.035","article-title":"Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming","volume":"166","author":"Buck","year":"2016","journal-title":"Cell"},{"key":"R108-20250602","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13045-022-01255-x","article-title":"Rewiring mitochondrial metabolism to counteract exhaustion of CAR-T cells","volume":"15","author":"Huang","year":"2022","journal-title":"J Hematol Oncol"},{"key":"R109-20250602","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1182\/blood.2018885863","article-title":"Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy","volume":"134","author":"van Bruggen","year":"2019","journal-title":"Blood"},{"key":"R110-20250602","doi-asserted-by":"crossref","first-page":"E761","DOI":"10.1073\/pnas.1620433114","article-title":"Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity","volume":"114","author":"Chamoto","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R111-20250602","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1242\/jcs.113662","article-title":"PGC1\u03b1 and mitochondrial metabolism--emerging concepts and relevance in ageing and neurodegenerative disorders","volume":"125","author":"Austin","year":"2012","journal-title":"J Cell Sci"},{"key":"R112-20250602","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/cvr\/cvn098","article-title":"Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha","volume":"79","author":"Ventura-Clapier","year":"2008","journal-title":"Cardiovasc Res"},{"key":"R113-20250602","doi-asserted-by":"crossref","first-page":"884S","DOI":"10.3945\/ajcn.110.001917","article-title":"Regulation of PGC-1\u03b1, a nodal regulator of mitochondrial biogenesis","volume":"93","author":"Fernandez-Marcos","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"R114-20250602","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/s41423-020-0365-3","article-title":"Enforced PGC-1\u03b1 expression promotes CD8 T cell fitness, memory formation and antitumor immunity","volume":"18","author":"Dumauthioz","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"R115-20250602","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.immuni.2016.08.009","article-title":"The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction","volume":"45","author":"Scharping","year":"2016","journal-title":"Immunity"},{"key":"R116-20250602","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006522","article-title":"Metabolic reprogramming via an engineered PGC-1\u03b1 improves human chimeric antigen receptor T-cell therapy against solid tumors","volume":"11","author":"Lontos","year":"2023","journal-title":"J Immunother Cancer"},{"key":"R117-20250602","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1084\/jem.20171068","article-title":"4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses","volume":"215","author":"Menk","year":"2018","journal-title":"J Exp Med"},{"key":"R118-20250602","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s00262-023-03407-5","article-title":"Mitochondrial C1QBP is essential for T cell antitumor function by maintaining mitochondrial plasticity and metabolic fitness","volume":"72","author":"Tian","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"R119-20250602","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612837","article-title":"\u03b22-Adrenergic Receptor Mediated Inhibition of T Cell Function and Its Implications for CAR-T Cell Therapy","volume":"24","author":"Farooq","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R120-20250602","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00262-018-2243-8","article-title":"\u03b2-Adrenergic signaling blocks murine CD8+ T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress","volume":"68","author":"Qiao","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"R121-20250602","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1158\/2326-6066.CIR-20-0445","article-title":"Chronic Adrenergic Stress Contributes to Metabolic Dysfunction and an Exhausted Phenotype in T Cells in the Tumor Microenvironment","volume":"9","author":"Qiao","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"R122-20250602","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030394","article-title":"Adrenergic Signaling in Immunotherapy of Cancer: Friend or Foe","volume":"13","author":"Jensen","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R123-20250602","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cmet.2023.12.010","article-title":"Mitochondrial isocitrate dehydrogenase impedes CAR T\u00a0cell function by restraining antioxidant metabolism and histone acetylation","volume":"36","author":"Si","year":"2024","journal-title":"Cell Metab"},{"key":"R124-20250602","doi-asserted-by":"crossref","first-page":"eadf9522","DOI":"10.1126\/sciadv.adf9522","article-title":"Mitochondrial metabolic flexibility is critical for CD8+ T cell antitumor immunity","volume":"9","author":"Chen","year":"2023","journal-title":"Sci Adv"},{"key":"R125-20250602","doi-asserted-by":"crossref","first-page":"12506","DOI":"10.1038\/s41598-022-16616-2","article-title":"Transgenic expression of IL-7 regulates CAR-T cell metabolism and enhances in vivo persistence against tumor cells","volume":"12","author":"Li","year":"2022","journal-title":"Sci Rep"},{"key":"R126-20250602","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cell.2015.03.021","article-title":"IL-7-Induced Glycerol Transport and TAG Synthesis Promotes Memory CD8+ T Cell Longevity","volume":"161","author":"Cui","year":"2015","journal-title":"Cell"},{"key":"R127-20250602","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.immuni.2011.12.007","article-title":"Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development","volume":"36","author":"van der Windt","year":"2012","journal-title":"Immunity"},{"key":"R128-20250602","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1158\/2326-6066.CIR-18-0466","article-title":"IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype","volume":"7","author":"Alizadeh","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"R129-20250602","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41590-021-00940-2","article-title":"Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity","volume":"22","author":"Guo","year":"2021","journal-title":"Nat Immunol"},{"key":"R130-20250602","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-023-02060-8","article-title":"IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases","author":"Zhao","year":"2024","journal-title":"Nat Biotechnol"},{"key":"R131-20250602","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1158\/0008-5472.CAN-19-1196","article-title":"The NOTCH-FOXM1 Axis Plays a Key Role in Mitochondrial Biogenesis in the Induction of Human Stem Cell Memory-like CAR-T Cells","volume":"80","author":"Kondo","year":"2020","journal-title":"Cancer Res"},{"key":"R132-20250602","doi-asserted-by":"crossref","first-page":"15338","DOI":"10.1038\/ncomms15338","article-title":"Notch-mediated conversion of activated T cells into stem cell memory-like T cells for adoptive immunotherapy","volume":"8","author":"Kondo","year":"2017","journal-title":"Nat Commun"},{"key":"R133-20250602","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1158\/2767-9764.CRC-21-0034","article-title":"Rejuvenating Effector\/Exhausted CAR T Cells to Stem Cell Memory-Like CAR T Cells By Resting Them in the Presence of CXCL12 and the NOTCH Ligand","volume":"1","author":"Ando","year":"2021","journal-title":"Cancer Res Commun"},{"key":"R134-20250602","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1111\/cas.13648","article-title":"Generation and application of human induced-stem cell memory T cells for adoptive immunotherapy","volume":"109","author":"Kondo","year":"2018","journal-title":"Cancer Sci"},{"key":"R135-20250602","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.celrep.2019.03.066","article-title":"Pulsatile MEK Inhibition Improves Anti-tumor Immunity and T Cell Function in Murine Kras Mutant Lung Cancer","volume":"27","author":"Choi","year":"2019","journal-title":"Cell Rep"},{"key":"R136-20250602","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1111\/cas.15074","article-title":"Inhibition of MEK pathway enhances the antitumor efficacy of chimeric antigen receptor T cells against neuroblastoma","volume":"112","author":"Tomida","year":"2021","journal-title":"Cancer Sci"},{"key":"R137-20250602","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41590-020-00818-9","article-title":"MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects","volume":"22","author":"Verma","year":"2021","journal-title":"Nat Immunol"},{"key":"R138-20250602","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41375-017-0008-6","article-title":"PI3K orchestration of the in vivo persistence of chimeric antigen receptor-modified T cells","volume":"32","author":"Zheng","year":"2018","journal-title":"Leukemia"},{"key":"R139-20250602","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1182\/bloodadvances.2017011254","article-title":"Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3K\u03b4 inhibitors and VIP antagonists","volume":"2","author":"Petersen","year":"2018","journal-title":"Blood Adv"},{"key":"R140-20250602","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/eji.201948455","article-title":"Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8+ T cells","volume":"50","author":"Dwyer","year":"2020","journal-title":"Eur J Immunol"},{"key":"R141-20250602","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1158\/0008-5472.CAN-23-0801","article-title":"Progressively enhancing stemness of adoptively transferred T cells with PI3Kdelta blockade improves metabolism and anti-tumor immunity","volume":"84","author":"Rangel Rivera","year":"2024","journal-title":"Cancer Res"},{"key":"R142-20250602","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1182\/blood.2021011597","article-title":"PI3K\u03b4\/\u03b3 inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity","volume":"139","author":"Funk","year":"2022","journal-title":"Blood"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T19:07:50Z","timestamp":1748891270000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":141,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003046","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,19]]},"assertion":[{"value":"2023-11-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}